Evidence map›Paper›PMID 21740659›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2011

The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessment.

C Rocha, R Montoya, K Zevallos, A Curatola, W Ynga, J Franco, F Fernandez, N Becerra, M Sabaduche, M A Tovar and 9 more

Abstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 7 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 7 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2020
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. 1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  15. Review
  16. Tuberculosis care models for children and adolescents: a scoping review.Bulletin of the World Health Organization · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

C RochaIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
R MontoyaIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru.
K ZevallosIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
A CuratolaIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
W YngaAsociación Benéfica Prisma, Lima, Peru; Microfinanzas Prisma, Lima, Peru.
J FrancoAsociación Benéfica Prisma, Lima, Peru; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
F FernandezIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru.
N BecerraIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru.
M SabaducheAsociación Benéfica Prisma, Lima, Peru.
M A TovarIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
E RamosIFHAD: Innovation For Health And Development, London, UK; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
A TapleyIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru.
N R AllenIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru.
D A OnifadeIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru.
C D AcostaIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru.
M MaritzIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru.
D F ConchaMicrofinanzas Prisma, Lima, Peru.
S G SchumacherIFHAD: Innovation For Health And Development, London, UK; Asociación Benéfica Prisma, Lima, Peru; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
C A EvansIFHAD: Innovation For Health And Development, London, UK; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru; Wellcome Centre for Clinical Tropical Medicine and Department of Infection & Immunity, Imperial College, London, UK; and Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Prisma · PEUniversidad Peruana Cayetano Heredia · PEJohns Hopkins University · US

Funding

Wellcome Trust 057434
6 · The paper itself

Abstract

settingTuberculosis (TB) affected households in impoverished shantytowns, Lima, Peru.

objectiveTo evaluate socio-economic interventions for strengthening TB control by improving uptake of TB care and prevention services.

designBarriers to TB control were characterised by interviews with TB-affected families. To reduce these barriers, a multidisciplinary team offered integrated community and household socio-economic interventions aiming to: 1) enhance uptake of TB care by education, community mobilisation and psychosocial support; and 2) reduce poverty through food and cash transfers, microcredit, microenterprise and vocational training. An interim analysis was performed after the socio-economic interventions had been provided for 2078 people in 311 households of newly diagnosed TB patients for up to 34 months.

resultsPoverty (46% earned <US$1 per day), depression (40%), stigmatisation (77%), and perceived isolation (39%) were common among TB patients (all P < 0.05 vs. non-patients). The project had 100% recruitment, and involved 97% of TB-affected households in regular visits, 71% in community groups, 78% in psychosocial support and 77% in poverty-reduction interventions. The socio-economic interventions were associated with increases in household contact TB screening (from 82% to 96%); successful TB treatment completion (from 91% to 97%); patient human immunodeficiency virus testing (from 31% to 97%); and completion of preventive therapy (from 27% to 87%; all P < 0.0001).

conclusionsSocio-economic interventions can strengthen TB control activities. KEYWORDS: tuberculosis; control; microcredit; poverty;social determinants.

Indexed as

Health Care CostsSocioeconomic FactorsCommunicable Disease ControlCommunity NetworksDeveloping CountriesFinancial ManagementHealth BehaviorHealth Knowledge, Attitudes, PracticeHealth PromotionHealth Services AccessibilityHumansIncomeNutritional StatusPatient Acceptance of Health CarePatient Education as TopicPeru

Identifiers

PMID21740659
PMCPMC3160483
OpenAlexW1991275886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.